Zylox-Tonbridge Medical Technology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Zylox-Tonbridge Medical Technology has a total shareholder equity of CN¥3.1B and total debt of CN¥75.0M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are CN¥3.5B and CN¥376.9M respectively.
Anahtar bilgiler
2.4%
Borç/özkaynak oranı
CN¥75.00m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥1.17b |
| Eşitlik | CN¥3.11b |
| Toplam yükümlülükler | CN¥376.86m |
| Toplam varlıklar | CN¥3.49b |
Son finansal sağlık güncellemeleri
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30
We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05Recent updates
Market Participants Recognise Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Revenues Pushing Shares 27% Higher
Oct 02Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business
Sep 27Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 2190's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥358.6M).
Uzun Vadeli Yükümlülükler: 2190's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥18.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 2190 has more cash than its total debt.
Borcun Azaltılması: Insufficient data to determine if 2190's debt to equity ratio has reduced over the past 5 years.
Borç Kapsamı: 2190's debt is well covered by operating cash flow (294.7%).
Faiz Kapsamı: Insufficient data to determine if 2190's interest payments on its debt are well covered by EBIT.